Gastrointestinal (GI) Bleeding

exp date isn't null, but text field is

Intraluminal blood loss anywhere from the oropharynx to the anus. Classification: upper = above the  ligament of Treitz; lower = below the ligament of Treitz “Severe” GIB: defined as having associated  shock, orthostatic hypotension, fall in hematocrit by 6% (or decrease in Hb by 2 g/dL), or requiring  transfusion ≥2U PRBCs. Requires hospitalization.

Upper GI Bleeding (UGIB)

PUD caused by Helicobacter pyloriinfection or NSAID use is the most common cause of nonvariceal  UGI  bleeding.  Characteristic  findings  are  hematemesis,  melena,  or  (infrequently)  bright-red  blood  per rectum or a high serum BUN/creatinine ratio. Slow and/or chronic bleeding is suggested by iron  deficiency  and  is  typical  of  erosive  disease,  tumor,  esophageal  ulcer,  portal  hypertensive  gastropathy, Cameron lesion (erosions found within large hiatal hernias), and angiodysplasia. 

Table 10.1: Differential Diagnosis of Upper GI Bleeding 

Presentation 

Diagnosis 

Dyspepsia, H. pylori infection, NSAID use, 

anticoagulation, severe medical illness 

Peptic ulcer disease 

Stigmata of chronic liver disease, evidence of portal  hypertension or risk factors for cirrhosis (alcohol use, viral hepatitis) 

 Variceal bleeding 

History of heavy alcohol use and retching before  hematemesis, hematemesis following weightlifting,  or young woman with bulimia 

 Mallory-Weiss tear 

Heartburn, regurgitation, and dysphagia; usually  small-volume or occult bleeding 

 Esophagitis 

Progressive dysphagia, weight loss, early satiety,  or abdominal pain; usually small-volume or occult  bleeding 

Esophageal or gastric cancer 

NSAID use, heavy alcohol intake, severe medical  illness; usually small-volume or occult bleeding 

Gastroduodenal erosions 

Initial management

Assess severity: vital signs including orthostatic changes, JVP. Tachycardia (can be masked by βB  use)  suggests  10%  volume  loss,  orthostatic  hypotension  20%  loss,  shock  >30%  loss.  After  the  patient  is  stabilized,  upper  endoscopy  is  required  to  document  the  source  of  bleeding.  If  upper  endoscopy shows an ulcer, test for H. pylori infection.  

Resuscitation:  placement  of  2  large-bore  (18-gauge  or  larger)  intravenous  lines,  volume  replacement: NS or LR to achieve normal vital signs, urine output, and mental status. 

Pharmacological Treatment  For variceal bleeding refer to (10.4.2.3 Bleeding Esophageal Varices) 

For bleeding peptic ulcer disease 

C: pantoprazole (IV) 40mg 12hourly for 2-3days 

OR 

S: esomeprazole (IV) 40mg 12hourly for 2-3days 

Note: 

  • Treat high-risk ulcers endoscopically (haemoclips, thermal therapy, or injection therapy) and continuous IV PPI infusion for 72 hours. Blood transfusion to target haemoglobin level of 7 g/dl Repeat endoscopic therapy for continued bleeding
  • Surgery or interventional radiology if endoscopic therapy unsuccessful

Laboratory Investigations 

FBP, LFT, RFT.

Abdominal ultrasound

Viral hepatitis screening

H. pylori stool antigen

 

Lower gastrointestinal (GI) Bleeding

Acute, painless LGI bleeding in older adult patients is usually due to colonic diverticula or  angiodysplasia. Ten percent of rapid rectal bleeding has an UGI source. 

Consider outpatient follow-up or early discharge when: 

  • patient age <60 years
  • no hemodynamic instability
  • no evidence of gross rectal bleeding
  • identification of an obvious anorectal source of bleeding

Table 10.2: Differential Diagnosis of Lower GI Bleeding 

Presentation

Diagnosis

Painless, self-limited, massive hematochezia

Diverticular bleeding (most common overall cause)

Chronic blood loss or acute painless hematocheziain an older adult patient

Angiodysplasia

Stool positive for occult blood in an asymptomatic patient

Colonic polyp or cancer

Risk factors for atherosclerosis and evidence ofvascular disease in an older adult patient; typically,with LLQ abdominal pain

Ischemic colitis

Aoritc stenosis Angiodysplasia (Heyde Syndrome)

History of bloody diarrhea, tenesmus, abdominal pain, fever

IBD

Rapid UGI bleeding

Dieulafoy lesion (large, tortuous, submucosalarteriole)

Large hiatal hernia

Cameron lesion (mucosal erosions)

Recent liver or biliary procedure

Hemobilia

Necrotizing pancreatitis

Hemosuccus pancreaticus (bleeding frompancreas)

Aortic aneurysm repair

Aortoenteric fistula

Painless hematochezia in a young patient and normal upper endoscopy and colonoscopy

Meckel diverticulum

Mucocutaneous telangiectasias Hereditary hemorrhagic telangiectasia

Note: 

  • According to expert opinion, the blood transfusion threshold for patients with colonic bleeding is a haemoglobin value <9 g/dL (note this is different for the evidence-based threshold for UGI bleeding).
  • If  the  patient  is  hemodynamically  unstable,  resuscitate  the  patient  before  diagnostic  studies  are performed. Most episodes of LGI bleeding resolve spontaneously.
  • Colonoscopy is recommended early, usually within the first 48 hours of admission, and endoscopic therapy is used to control continued bleeding.
  • If colonoscopy does not identify a discrete lesion or endoscopic therapy does not control the bleeding, interventional angiography or surgery may be indicated.
  • Patients  with  angiodysplasia  in  the  setting  of  AS  (Heyde  Syndrome)  may  benefit  from  valve replacement surgery.

 

Bleeding of Obscure Origin

Obscure GI bleeding is recurrent blood loss without an identified source of bleeding despite upper  endoscopy and colonoscopy.Patients aged ≤50 years are more likely to have tumors (leiomyomas,  carcinoid, adenocarcinoma, or lymphoma), Dieulafoylesion, or Crohn’s disease. Older patients are  more likely to have vascular lesions, such as angiodysplasia. Angiodysplasia is the most common  cause of obscure GI bleeding overall (40% of all cases). Patients may present with either melena or  hematochezia or positive fecal occult blood test (FOBT). The first step is to repeat upper endoscopy  and/or colonoscopy, which is diagnostic in approximately 40% of cases. 

For patients with obscure active GI bleeding 

  • nuclear studies (technetium 99m-labeled erythrocyte or sulfur colloid nuclear scan) first,  followed by angiography
  • if unrevealing consider push enteroscopy or balloon-assisted enteroscopy (deep enteroscopy)
  • surgery and intraoperative enteroscopy is a last diagnostic option

For patients with occult GI bleeding 

  • capsule endoscopy (first choice GIE 2015; 81:889) or deep enteroscopy
  • if unrevealing, repeat endoscopic examinations (upper endoscopy, colonoscopy, capsule endoscopy), or deep enteroscopy